mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.008 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.009 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |